Journal of Surgery Concepts & Practice ›› 2020, Vol. 25 ›› Issue (04): 354-358.doi: 10.16139/j.1007-9610.2020.04.018
• Review • Previous Articles Next Articles
HUANG Zhiye, LIANG Haibin, CHEN Lei(
)
Received:2019-10-09
Online:2020-07-25
Published:2022-07-18
Contact:
CHEN Lei
E-mail:chenlei@xinhuamed.com.cn
CLC Number:
HUANG Zhiye, LIANG Haibin, CHEN Lei. Research progress of circulating exosomal miRNA use in diagnosis and treatment of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2020, 25(04): 354-358.
| 参考文献 | miRNA | 实验组 （n） | 对照组 （n） | 样本类型 | 方法 | TNM Ⅰ/Ⅱ/Ⅲ/Ⅳ | HR | ROC的AUC | 特异度/ 灵敏度 | 临床 应用 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liu等[ | has-miR- 122-5p | 30 | 30 | 人血清 外泌体 | 二代测序、 qRT-PCR | / | / | 0.67 | 86%/62% | 诊断 |
| Shi等[ | miR-1246 | 85 | 50 | 人血清 外泌体 | qRT-PCR | 28/32/14/11 | / | 0.84、 0.81 | 74%/85%、 80%/78% | 诊断/ 预后 |
| Yang等[ | miR-423-5p | 80 | 80 | 人血清 外泌体 | qRT-PCR | 18/15/20/27 | / | 0.76 | 57%/ 81% | 诊断/ 预后 |
| Wang等[ | miR-19b联 合miR-106a | 90 | 90 | 人血清 外泌体 | qRT-PCR | / | / | 0.81 | 90%/ 95% | 诊断/ 预后 |
| Huang等[ | miR10b-5p、 miR132-3p、 miR185-5p、 miR195-5p、 miR-20a3p、 miR2965p | 49 154 | 47 120 | 人血清 | miRNA芯片、 qRT-PCR | 11/10/23/5 35/33/65/21 | / | 0.76、 0.70、 0.70 | / | 诊断/ 预后 |
| Bai等[ | miR-135b | 1 977 | 1 974 | 人血清 外泌体 | qRT-PCR | / | 0.68 | / | / | 诊断/ 预后 |
| Kumata等[ | miR-23b | 232 | 20 | 人血清 外泌体 | miRNA芯片、 qRT-PCR | 74/47/79/32 | 0.45 | / | / | 诊断/ 预后 |
| Ren等[ | miR-107 | 16 | 16 | 人血清 外泌体 | qRT-PCR | / | / | / | / | 诊断 |
| Huang等[ | miR-1 290 | / | / | 人血清 外泌体 | qRT-PCR | / | / | / | / | 诊断 |
| Liu等[ | miR-451 | 76 | 42 | 人血清 外泌体 | qRT-PCR | 12/22/24/18 | 4.34 | / | / | 诊断/ 预后 |
| Ma等[ | miR-221 | 40 | 20 | 人血清 外泌体 | qRT-PCR | 5/15/18/2 | / | / | / | 预后 |
| 魏玮等[ | 多个 | 6 | 6 | 人血清 外泌体 | 二代测序、 qRT-PCR | Ⅰ+Ⅱ/Ⅲ+Ⅳ 0/6 | / | / | / | 耐药 |
| Zheng等[ | miR-21 | / | / | 细胞上 清液 | qRT-PCR | / | / | / | / | 耐药 |
| Wang等[ | miR-214 | / | / | 鼠血清 外泌体 | qRT-PCR | / | / | / | / | 耐药/ 治疗 |
| [1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
doi: 10.3322/caac.21262 URL |
| [2] | Shen L, Shan YS, Hu HM, et al. Management of gastric cancer in Asia: resource-stratified guidelines[J]. Lancet Oncol, 2013, 14(12):e535-e547. |
| [3] |
Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice[J]. Lancet Oncol, 2008, 9(3):279-287.
doi: 10.1016/S1470-2045(08)70072-X pmid: 18308253 |
| [4] |
Shimada H, Noie T, Ohashi M, et al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association[J]. Gastric Cancer, 2014, 17(1):26-33.
doi: 10.1007/s10120-013-0259-5 URL |
| [5] | Mathai RA, Vidya RVS, Reddy BS, et al. Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology[J]. J Clin Med, 2019, 8(3).pii:E373. |
| [6] |
Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis[J]. Cancer Cell, 2016, 30(6):836-848.
doi: 10.1016/j.ccell.2016.10.009 URL |
| [7] |
Huang T, Song C, Zheng L, et al. The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy[J]. Mol Cancer, 2019, 18(1):62.
doi: 10.1186/s12943-019-0967-5 URL |
| [8] |
Ying W, Riopel M, Bandyopadhyay G, et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity[J]. Cell, 2017, 171(2):372-384,e12.
doi: S0092-8674(17)30993-5 pmid: 28942920 |
| [9] |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci U S A, 2008, 105(30):10513-10518.
doi: 10.1073/pnas.0804549105 pmid: 18663219 |
| [10] |
Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute 2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma[J]. Proc Natl Acad Sci U S A, 2011, 108(12):5003-5008.
doi: 10.1073/pnas.1019055108 pmid: 21383194 |
| [11] |
Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes[J]. PloS One, 2012, 7(3):e30679.
doi: 10.1371/journal.pone.0030679 URL |
| [12] |
Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients[J]. Nat Rev Cancer, 2011, 11(6):426-437.
doi: 10.1038/nrc3066 pmid: 21562580 |
| [13] |
Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends[J]. J Cell Biol, 2013, 200(4):373-383.
doi: 10.1083/jcb.201211138 pmid: 23420871 |
| [14] | Larrea E, Sole C, Manterola L, et al. New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies[J]. Int J Mol Sci, 2016, 17(5).pii:E627. |
| [15] |
Liu H, Li PW, Yang WQ, et al. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs[J]. BMC Cancer, 2019, 19(1):129.
doi: 10.1186/s12885-019-5328-7 URL |
| [16] | Shi Y, Wang Z, Zhu X, et al. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer[J]. Int J Clin Oncol,2019-09-10. [Epub ahead of print] |
| [17] |
Yang H, Fu H, Wang B, et al. Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer[J]. Mol Carcinog, 2018, 57(9):1223-1236.
doi: 10.1002/mc.22838 URL |
| [18] |
Bai M, Li J, Yang H, et al. miR-135b delivered by gastric tumor exosomes inhibits foxo1 expression in endothelial cells and promotes angiogenesis[J]. Mol Ther, 2019, 27(10):1772-1783.
doi: 10.1016/j.ymthe.2019.06.018 URL |
| [19] | Kumata Y, Iinuma H, Suzuki Y, et al. Exosome-encapsulated microRNA23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage[J]. Oncol Rep, 2018, 40(1):319-330. |
| [20] |
Ren W, Zhang X, Li W, et al. Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer[J]. Cancer Manag Res, 2019, 11:4023-4040.
doi: 10.2147/CMAR.S198886 URL |
| [21] |
Huang J, Shen M, Yan M, et al. Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1[J]. Acta Biochim Biophys Sin (Shanghai), 2019, 51(9):900-907.
doi: 10.1093/abbs/gmz077 URL |
| [22] |
Liu F, Bu Z, Zhao F, Xiao D. Increased T-helper 17 cell differentiation mediated by exosome-mediated microRNA-451 redistribution in gastric cancer infiltrated T cells[J]. Cancer Science, 2018, 109(1):65-73.
doi: 10.1111/cas.13429 URL |
| [23] |
Wang N, Wang L, Yang Y, et al. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer[J]. Biochem Biophys Res Commun, 2017, 493(3):1322-1328.
doi: 10.1016/j.bbrc.2017.10.003 URL |
| [24] |
Huang Z, Zhu D, Wu L, et al. Six serum-based miRNAs as potential diagnostic biomarkers for gastric cancer[J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(2):188-196.
doi: 10.1158/1055-9965.EPI-16-0607 URL |
| [25] |
Ma M, Chen S, Liu Z, et al. miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer[J]. Onco Targets Ther, 2017, 10:4161-4171.
doi: 10.2147/OTT.S143315 URL |
| [26] | 魏玮, 王艺, 李霖, 等. 5-氟尿嘧啶耐药的晚期胃癌病人血清外泌体miRNA表达谱分析[J]. 肿瘤, 2017, 37(10):1047-1055. |
| [27] |
Zheng P, Chen L, Yuan X, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells[J]. J Exp Clin Cancer Res, 2017, 36(1):53.
doi: 10.1186/s13046-017-0528-y URL |
| [28] |
Li BS, Zhao YL, Guo G, et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection[J]. PloS One, 2012, 7(7):e41629.
doi: 10.1371/journal.pone.0041629 URL |
| [29] |
Wang X, Zhang H, Bai M, et al. Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer[J]. Mol Ther, 2018, 26(3):774-783.
doi: 10.1016/j.ymthe.2018.01.001 URL |
| [1] | YAN Chao, LU Sheng, YAN Min, ZHU Zhenggang. Chinese interpretation of Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) and Ruijin clinical practice [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 326-354. |
| [2] | SUN Qi, HUANG Wenbo, HE Bingliang, LIU Chang, XU Yuhang, ZHAO Wei. Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 366-370. |
| [3] | SUN Qiang, YAO Jun, ZHANG Xin, DU Shanshan, WANG Weijun. Research progress of anti reflux digestive tract reconstruction for proximal gastrectomy [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 388-393. |
| [4] | YAN Su, ZHENG Minhua. Practice of single-port and reduced-port laparoscopic gastric cancer surgery in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 233-239. |
| [5] | HU Wenqing, YANG Yinhao, CUI Peng, WEI Wei. Current status of high-positioned digestive tract reconstruction after laparoscopic proximal stomach and lower esophagus resection through the abdominal-left diaphragmatic approach for adenocarcinoma of esophagogastric junction [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 226-232. |
| [6] | FAN Qingquan, SONG Xiaoling, GU Jun. Exosome in gastric cancer: research and perspective [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 177-180. |
| [7] | DENG Shijie, YUAN Fei. Advances in diagnosis and molecular detection of EBV-positive gastric cancer and gastric cancer with lymphoid stroma [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 53-57. |
| [8] | ZHANG Huan, CHEN Yong. New progression of radiomics in diagnosis of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 42-48. |
| [9] | LIU Wentao, LIU Fukun. Summary and prospect of perioperative comprehensive treatment for gastric cancer in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 36-41. |
| [10] | LI Guoli, GUO Feilong. Preoperative chemotherapy through intra-arterial combined with intra-venous administration in treatment of advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 31-35. |
| [11] | ZHAO Fazhi, ZHAO Ping. Formation and improvement of surgery-based treatment system for gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30. |
| [12] | LU Yiming, XIONG Jianping, TIAN Yantao. Current status and prospect of conversion therapy for far-advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 17-23. |
| [13] | LI Jianfang, YU Junxian, YAN Chao, ZHU Zhenggang, LIU Bingya. Hotspots in basic and translational research of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 7-16. |
| [14] | ZHU Zhenggang. Progress and prospect of surgical comprehensive treatment of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6. |
| [15] | LUO Xi, SHI Yongmei, CHEN Ke, JIANG Shuo, WU Yuwei. Analysis on evaluation of patients with gastric and colon cancer using modified patient-generated subjective global assessment [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 545-550. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
